The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID 19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
The ESPGHAN 2012 coeliac disease (CD) diagnostic guidelines aimed to guide physicians in accurately diagnosing CD and permit omission of duodenal biopsies in selected cases. Here, an updated and expanded evidence-based guideline is presented.
This guideline covers diagnosing and managing gastro-oesophageal reflux disease in children and young people (under 18s). It aims to raise awareness of symptoms that need investigating and treating, and to reassure parents and carers that regurgitation is common in infants under 1 year.
This guideline covers the management of Crohn’s disease in children, young people and adults. It aims to reduce people’s symptoms and maintain or improve their quality of life.
This guideline covers the management of ulcerative colitis in children, young people and adults. It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with ulcerative colitis.
Fraile Astorga G, Aparicio Rodrigo M. Evid Pediatr. 2023;19:25
Artículo original: Yu ZT, Song JM, Qiao l, Wang Y, Chen Y, Wang EH, et al. A Randomized, Double-Blind, Controlled Trial of Percutaneous Tibial Nerve Stimulation With Pelvic Floor Exercises in the Treatment of Childhood Constipation. Am J Gastroenterol. 2023; 118:553-60.
Flores Villar S, Molina Arias M. Evid Pediatr. 2023;19:15
Artículo original: Donat E, Roca M, Castillejo G, Sánchez-Valverde F, García-Burriel JI, Martínez-Ojinaga E, et al; Coeliac Disease Working Group of the Spanish Gastroenterology, Hepatology, Paediatric Nutrition Society (SEGHNP). Correlation of anti-tissue transglutaminase antibodies with the mucosal changes and IgA status of children with celiac disease. J Pediatr Gastroenterol Nutr. 2022;75:743-8.
Rivero Martín MJ, Molina Arias M. Evid Pediatr. 2022;18:6
Artículo original: Milas GP, Fragkos S. Neutrophil to lymphocyte ratio and gastrointestinal involvement among Henoch Schonlein purpura patients: a systematic review and meta-analysis. J Pediatr Gastroenterol Nutr. 2021;73:437-43.
Ortega Páez E, Martín Masot R. Evid Pediatr. 2022;18:37
Artículo original: Kamphorst K, Vlieger AM, Oosterloo BC, Garssen J, van Elburg RM. Neonatal Antibiotics and Food Allergy Are Associated With FGIDs at 4-6 Years of Age. J Pediatr Gastroenterol Nutr. 2022;74:770-5.
Pérez-Moneo Agapito B, Molina Arias M. Evid Pediatr. 2021;17:43
Artículo original: Warschburger P, Calvano C, Becker S, Ebinger F, Hudert C, Iven E, et al. Do children with functional abdominal pain benefit more from a pain-specific cognitive-behavioral intervention than from an unspecific attention control intervention? Results of a randomized controlled trial. Am J Gastroenterol. 2021;116:1322-35.
Llerena Santa Cruz E, Pérez-Moneo Agapito B. Evid Pediatr. 2020;16:43
Artículo original: Harpavat S, García-Prats JA, Anaya C, Brandt M, Lupo PJ, Finegold MJ, et al. Diagnostic yield of newborn screening for biliary atresia using direct or conjugated bilirrubin measurements. JAMA. 2020; 323: 1141-50.
Ochoa Sangrador C, Andrés de Llano JM. Evid Pediatr. 2020;16:44
Artículo original: Rachel H, Griffith AF, Teague WJ, Hutson JM, Gibb S, Goldfeld S, et al. Polyethylene Glycol Dosing for Constipation in Children Younger Than 24 Months: A Systematic Review. J Pediatr Gastroenterol Nutr. 2020;71:171-5.
Aizpurua Galdeano P, Aparicio Rodrigo M. Evid Pediatr. 2020;16:9
Artículo original: Lund-Blix NA, Mårild K, Tapia G, Norris JM, Stene LC, Størdal K. Gluten intake in early childhood and risk of celiac disease in childhood: a nationwide cohort study. Am J Gastroenterol. 2019;114:1299-306.
Molina Arias M, Pérez-Moneo Agapito B. Evid Pediatr. 2019;15:45
Artículo original: Malchodi L, Wagner K, Susi A, Gorman G, Hisle-Gorman E. Early acid suppression therapy exposure and fracture in young children. Pediatrics. 2019;144: e20182625.
Pérez-Moneo Agapito B, Llerena Santa Cruz E. Evid Pediatr. 2019;15:38
Artículo original: Olén O, Askling J, Sachs MC, Frumento P, Neovius M, Smedby KE, et al. Increased mortality of patients with childhood-onset inflammatory bowel diseases, compared with the general population. Gastroenterology. 2019;156:614-22.
Juanes de Toledo B, Martín Masot R. Evid Pediatr. 2019;15:2
Artículo original: Schnadower D, Tarr PI, Casper TC, Gorelick MH, Dean JM, O’Connell KJ, et al. Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children. N Engl J Med. 2018 Nov 22;379:2002-2014.
Down syndrome is phenotypically variable, but programs have been introduced to capitalize on each person’s best abilities. Guidelines for surveillance of the many associated medical problems and guidance for managing problems that are unique to Down syndrome are available.